Parents' hands forming a heart around a newborn's feet

The Donor Process

Only healthy families who meet or exceed strict screening criteria are considered as donors.

Screening

It begins with the donor family

The labs' proprietary process begins with meticulous screening of the donor mother and father as well as family members through several generations.

In addition to routine industry screens for bloodborne pathogens, they also screen for heritable and non-heritable conditions, environmental contaminants from medications, alcohol, drugs, tobacco, and electronic vaping. Only healthy families who meet or exceed these criteria are considered as donors with the labs.

Postnatal tissue donations are collected following birth and processed according to the manufacturer’s procedures. Contact us for available documentation about collection, processing, testing, and storage.

We Put Families First

Products undergo the screening and testing specified in the manufacturer’s procedures. Screening and testing cannot eliminate every potential risk.

Testing

Diseases tested for donation eligibility

Hepatitis Bs AgHepatitis Bc AbHTLV I/II AbHepatitis C AbHIV 1&2 Plus O AbCMV AbRPR (Non-treponemal syphilis)HIV-1/HCV/HBVCOVID-19
Our process

How It's Done

From donation to delivery, each stage supports product quality and traceability.

  1. 01

    Donor screening

    Donor screening and product testing are components of the manufacturer’s quality-control process. Medical history, risk factors, and required blood tests are reviewed.

  2. 02

    Birth & donation

    Postnatal tissue is donated following a full-term, live birth. A licensed recovery professional collects the donation at the designated hospital.

  3. 03

    Collection & transport

    The recovery specialist arranges transport to the laboratory, where the donation is documented and prepared for processing.

  4. 04

    Cleaning

    Tissue is cleaned before processing and handled using aseptic protocols to minimize contamination.

  5. 05

    Processing

    Tissue is recorded and organized into controlled lots. Contact us for available manufacturer information about product processing and handling procedures.

  6. 06

    Cryopreservation

    Processed tissue is cryopreserved and stored under product-specific conditions. Follow the manufacturer’s storage and handling instructions.

  7. 07

    Quarantine & testing

    All lots are quarantined for 14 days and thoroughly tested for bacterial and disease contamination by a CLIA-certified lab.

  8. 08

    Review & release

    Required testing and donor records are reviewed. Once authorized by the manufacturer’s medical director, the lot is released into inventory.

  9. 09

    Shipping & receipt

    Products are shipped to the clinic under the manufacturer’s specified conditions. Clinic staff follow the accompanying receipt and storage instructions.

  10. 10

    Preparation & use

    A licensed healthcare professional prepares and uses the product according to the manufacturer’s instructions and applicable homologous-use requirements.

100% Chain of Custody

Chain-of-custody documentation tracks tissue from donation through processing and delivery. Contact us for available product-specific records.

Traceability

A Tissue ID connects the records

Each product is assigned a Tissue ID number that links it to the manufacturer’s donation and processing records.

This identifier supports traceability from the original donation through processing and delivery. Healthcare professionals can request available documentation associated with their product and retain the identifier with their clinic records.

What to keep on file

Retain the Tissue ID, lot or batch identifier, shipment details, and accompanying manufacturer records. Contact Cellulam Core with these identifiers when requesting product documentation.

Get in touch

Want to learn more about our providers?

Contact us for details on donor screening, testing, and chain of custody.